Trial Profile
A Prospective Multicentre Phase II Trial of Zoledronic Acid in Patients With Myelofibrosis With Myeloid Metaplasia (MMM)
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 28 Sep 2022
Price :
$35
*
At a glance
- Drugs Zoledronic acid (Primary)
- Indications Myelofibrosis
- Focus Pharmacodynamics
- 01 Dec 2010 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 27 Oct 2009 New trial record